Coumarinic compounds having IgE affecting properties
US6451829B2 · kind B2 · utility
6Cited by
1References
10Claims
0Family size
Inventors
Key dates
| Filing date | Jun 14, 2001 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Jun 14, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to small molecule inhibitors of the IgE response to allergens which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.